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Abstract
Objective—Some evidence suggests that Hatha yoga might be an effective practice to reduce 
anxiety. To examine the effect of Hatha yoga on anxiety, we conducted a meta-analysis of relevant 
studies extracted from PubMed, PsycINFO, the Cochrane Library, and manual searches.
Methods—The search identified 17 studies (11 waitlist controlled trials) totaling 501 participants 
who received Hatha yoga and who reported their levels of anxiety before and after the practice. We 
estimated the controlled and within-group random effects of the practice on anxiety.
Results—The pre-post within-group and controlled effect sizes were, Hedges’ g = 0.44 and 
Hedges’ g = 0.61, respectively. Treatment efficacy was positively associated with the total number 
of hours practiced. People with elevated levels of anxiety benefitted the most. Effect sizes were not 
moderated by study year, gender, presence of a medical disorder, or age. Although the quality of 
the studies was relatively low, the risk of study bias did not moderate the effect.
Conclusions—Hatha yoga is a promising method for treating anxiety. However, more well-
controlled studies are needed to compare the efficacy of Hatha yoga with other more established 
treatments and to understand its mechanism.
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Introduction
Anxiety and its disorders are common mental health problems that are associated with high 
comorbidity, suffering, and societal burden (1). Recently, mindfulness practices have shown 
some promise for reducing anxiety symptoms (2, 3). However, these treatments are still not 
widely disseminated. In contrast, yoga, which shares many similarities to psychological 
mindfulness-based treatments, is more readily available and its popularity is increasing. In 
fact, Yoga has been adopted by the advertising industry as a symbol of health and a 
wholesome lifestyle. Based on a 2007 National Health Interview Survey (NHIS), yoga was 
the sixth most commonly used complementary health practice among adults, and between 
the 2002 and 2007 NHIS, use of yoga among adults increased by 1 percent or approximately 
3 million people (4). The most commonly practiced form of yoga in the USA is Hatha yoga 
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(5). Meditation is a core component of this yoga practice, both historically and in practice. 
This notion is consistent with the definition of Hatha yoga by the National Center for 
Complementary and Integrative Health (6), which considers meditation an important 
component next to physical postures, breathing exercises, and a distinct philosophy as of 
yoga.
Despite its popularity, no quantitative review of Hatha yoga as a possible treatment for 
anxiety exists. Therefore, the goal of the present study was to provide a systematical review 
of the efficacy of yoga for reducing anxiety symptoms. Although there are many different 
forms of yoga practices, we limited our review the Hatha yoga, the most common form of 
yoga practice. We tested the hypothesis that Hatha yoga is an effective treatment for 
reducing symptoms of anxiety.
Methods
Search
A search of PubMed, PsycINFO and Cochrane Library databases was conducted on 
September 18, 2015. The following search terms were used: yoga AND (anxiety OR anxious 
OR panic OR agoraphobia OR social phobia OR social anxiety OR sad OR generalized 
anxiety OR gad OR obsessive compulsive OR obsessive-compulsive OR ocd OR specific 
phobia OR simple phobia OR post-traumatic stress OR post-traumatic stress OR 
posttraumatic stress OR ptsd OR acute stress OR asd). The initial search produced 2 234 
results, with 946 studies remaining after duplicates and resources reporting data presented in 
another selected study were excluded. In accordance with the guidelines set forth in 
Preferred Reporting Items for Systematic Reviews and Meta-analysis Protocols (7) the 
protocol for this meta-analyses was registered in with the International Prospective Register 
of Systematic Reviews (PROSPERO) on September 9, 2015, and was last updated on 
February 2, 2016 (registration number CRD42015026303).
Study Selection
Studies were included in the present meta-analysis if: 1) at least one treatment condition 
consisted of a course of Hatha yoga (i.e. no single-session interventions); 2) they included an 
adequate measure of anxiety at pre- and post-intervention; 3) they included a sample of 
adults 18 years or older; and 4) they provided sufficient data on the intervention of interest 
for calculating an effect size to use in our meta-analysis.
Studies were excluded if: 1) the bibliographic resource was a review, a meta-analysis, a 
survey, a manual or a conference abstract; 2) Hatha yoga was not described as “pure” Hatha, 
meaning: a) the authors explicitly define that just one or some component of Hatha yoga 
were used (e.g. only breathing or poses); b) Hatha yoga was defined as explicitly and 
drastically modified from the traditional method, with the introduction of not-conventional 
procedures; or c) the yoga descriptions were too ambiguous to define the yoga style as 
Hatha; 3) Hatha yoga was administered in conjunction with another active treatment. In 
cases of disagreement, the authors discussed the case until consensus was reached. If a study 
met all other inclusion criteria, but the data necessary to calculate an effect size were not 
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reported, we emailed the corresponding author to request the necessary data to conduct the 
analyses.
Data Extraction
For each selected study, the second author and four independent trained assessors extracted 
data on anxiety measures at pre-treatment and post-treatment for the Hatha yoga arms, along 
with data from non-active control conditions if included. In addition, we extracted data on 
sample and study characteristics, including sample size, duration and frequency of treatment, 
gender distribution, age, and whether the sample consisted of a medical population, and 
publication year. Because there is no standardized protocol for the delivery of Hatha yoga, 
we also identified and extracted the components of the interventions as described by the 
authors of each study, which included yoga postures, breathing techniques, relaxation, 
meditation, and other techniques such as mindfulness or acceptance. Data were extracted on 
two separate occasions by independent raters and compared to ensure reliability, with 
discrepancies resolved by the second author.
Risk of Bias Assessment
In accordance with the Cochrane guidelines for systematic reviews (8), we assessed study 
quality with the Cochrane Collaboration’s tool for assessing risk of bias (9). This tool 
involves assessing each study as containing a high, low or unclear level of bias risk in a 
number of domains using pre-specified criteria. The domains used in our assessment were: 
1) Sequence Generation, which assesses whether allocation of participants to treatment 
condition are adequately generated in a random manner; 2) Allocation Concealment, which 
assesses whether treatment assignment was adequately concealed from investigators and 
participants prior to randomization; 3) Incomplete Outcome Data, which assesses whether 
outcome data are missing at random and imputed using appropriate methods; and 4) 
Selective Outcome Reporting, which determines whether pre-specified outcome variables of 
interest are adequately and completely reported. Although this tool was initially designed for 
assessment of randomized controlled trials, the Cochrane guidelines specify that it may be 
adapted for the evaluation of non-randomized trials (8). In doing so, we assigned non-
randomized trials a high risk rating in the sequence generation category. Following 
recommendations from the Cochrane guidelines, a total bias assessment was created for each 
study such that an ‘unclear’ rating in any category meant an ‘unclear risk’ overall rating 
unless there was a ‘high’ rating in any category, which lead to a ‘high risk’ overall rating. 
‘Low risk’ studies had to be rated as ‘low’ in all four categories. The third and fourth authors 
independently rated each study and then met to resolve any discrepancies. Inter-rater 
reliability for the total bias assessment was strong (Kappa = .74; SE = .17).
Data Analyses
The meta-analytic procedures were conducted in Comprehensive Meta-Analysis, Version 3. 
We used a random effects model because of the heterogeneity within the studies. Within-
group and controlled effect sizes were calculated using Hedges’ g (10).
To investigate potential moderator effects on outcome, we employed the between-group 
heterogeneity statistic (QB) recommended by Hedges and Olkin (10) and meta-regression 
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procedures for categorical and continuous moderators, respectively. Moderators of interest 
included both study procedure characteristics (i.e., number of sessions, session frequency, 
study quality, study year) and sample characteristics (i.e., age, sex, presence of a medical 
condition).
To examine the presence of publication bias, we used the fail-safe N method to determine 
the number of additional studies with a null result needed to reduce the overall effect size to 
non-significance (11). We also examined the funnel plot to evaluate symmetry relative to the 
mean effect size, with greater symmetry corresponding to decreased likelihood of 
publication bias. To complement funnel plot inspection, the trim and fill method (12) was 
utilized to determine the nature of potential publication bias and compute an imputed effect 
size that accounts for such bias.
Results
Study Characteristics
Figure 1 shows the number of studies excluded at each stage of study selection, and the 
reasons for exclusion. Of the 2 234 studies initially identified, 17 were determined to be 
eligible (13–29). Together these studies examined the effect of yoga on anxiety symptoms in 
501 participants. Eleven of these studies contained waitlist controls allowing for the 
calculation of a between-groups effect size.
Study characteristics are presented in Table 1. Results from the risk of bias assessment 
showed that seven studies had an unclear risk of bias, nine had a high risk of bias, and one 
study had a low risk of bias. Across studies, the mean study sample consisted of 75.5% 
female participants (SD = 31.81), and had a mean age of the 41.08 (SD = 12.42). Mean 
treatment duration was 8.69 weeks (SD = 4.17), and mean session frequency was 2.25 times 
per week (SD = 1.31). All 14 of the studies that provided descriptions of the Hatha yoga 
included postures, and 13 of the 14 studies included breathing techniques. Five of the studies 
described using relaxation techniques, seven described the use of meditation, and two 
studies included other components (mindfulness and awareness/acceptance exercises).
Eight of the 17 studies examined the effect of yoga on anxiety in a sample with a medical 
condition, and one study examined a sample with a psychological condition (panic disorder). 
To assess the baseline anxiety severity of each study sample, we compared mean anxiety 
scores at pre-test to population norms and clinical cut-offs whenever possible (Table 2). Of 
the 13 studies that included anxiety measures where norms and clinical cut-offs were 
available, four used samples with mean anxiety scores above the clinical cut-off, and an 
additional three studies had samples with elevated anxiety levels that were significantly 
greater than population means. Population means and clinical cut-offs for the measures 
where such data were available were as follows: State Trait Anxiety Inventory – Trait (STAI; 
31): population mean = 36.35 (SD = 11.39; 39), clinical cut-off ≥46 (40); Beck Anxiety 
Inventory (BAI; 30): population mean = 6.16 (SD = 7.16; 39), clinical cut-off ≥16 (30); 
Hospital Anxiety and Depression Scale - anxiety subscale (HADS-A; 32): population mean 
= 4.7 (SD = 3.5; 41), clinical cut-off ≥8 (42); Hamilton Anxiety Rating Scale (HAM-A; 38): 
≥24 suggests severe anxiety (43); Depression Anxiety and Stress Scales (21 item version) – 
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Anxiety subscale (DASS21-A; 37): population mean = 1.74 (SD = 2.78; 39), clinical cut-off 
≥6 (44).
Quantitative Data Synthesis
Within-group effect sizes
a) Pre-post within-group effects: Within-group effect sizes, confidence intervals and 
significance values for each study are presented in Table 3. For the within-group analysis, 
one outlier (Hedges’ g = 5.63) was identified (28) and removed from subsequent analyses. 
The random effects meta-analysis yielded an overall effect size on anxiety of Hedges’ g = 
0.44 (95% CI: 0.25–0.63, z = 4.491, P < .001). The fail-safe N analysis for the within-group 
effect size was robust with N = 432 (z = 10.36). Inspection of the funnel plot reveals a 
distribution of effect sizes concentrated to the left of the mean effect size, which indicates a 
decreased likelihood of publication bias from small studies with disproportionately large 
effect sizes (Figure 2). Using the Trim and Fill method (12), no studies would need to fall to 
the left of the mean (i.e., have an effect size smaller than the mean) and 2 studies would need 
to fall to the right of the mean (i.e., have an effect size larger than the mean) to make the plot 
symmetrical, suggesting that the computed effect size is a conservative estimate. The 
random-effects model for the new imputed mean effect size revealed a Hedges’ g = 0.69 
(95% CI: 0.41–0.56).
b) Between-group effect sizes: Between-group effect sizes, confidence intervals and 
significance values for each study comparing yoga to a waitlist control are presented in 
Table 3. The between-groups random-effects meta-analysis yielded an overall effect size of 
Hedges’ g = 0.61 (95% CI: 0.25–0.98, z = 3.32, P = .001). The fail-safe N for this analysis 
was robust with N = 153 (z = 7.56). The Trim and Fill analysis revealed that no adjustments 
to the mean effect size was warranted as no studies would need to fall to the left or right of 
the mean to make the plot symmetrical, suggesting an unbiased effect size estimate.
Moderator Analyses—The results of the meta-regression analysis revealed that treatment 
efficacy was moderated by the total number of treatment hours (B = 0.005, SE = 0.002, P < 
0.05) and number of sessions per week (B = 0.18, SE = 0.05, P < 0.001). Clinical severity 
status also moderated treatment efficacy (QB = 4.65, df = 2, P < 0.05); studies containing 
subjects with clinically elevated anxiety symptoms demonstrated greater efficacy (Hedge’s g 
= 0.72; 95% CI: 0.34–1.09, z = 3.75, P = .001) than did those containing subjects without 
clinically elevated anxiety symptoms (Hedge’s g = 0.28; 95% CI: 0.13–0.42, z = 3.80, P = .
001). Effect sizes were not moderated by study year (B = 0.07, SE = 0.01, P = n.s.), 
percentage of males (B = −0.004, SE = 0.003, P = n.s.), presence of a medical disorder (B = 
−0.24, SE = 0.19, P = n.s.), mean age (B = −0.003, SE = 0.006, P = n.s.), or risk of study 
bias (QB = 4.06, df = 2, P = n.s.).
Discussion
To examine the effect of Hatha yoga on anxiety, we reviewed a total of 2 234 studies. We 
identified 17 studies (501 participants) that met the study inclusion criteria. The within-
group analysis revealed an overall effect size on anxiety of Hedges’ g = 0.44. This effect size 
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was robust with a low likelihood for a publication bias. In fact, the funnel plot analysis 
suggested that the obtained effect size was a conservative estimate. The imputed mean effect 
size (Hedges’ g = 0.69) was similar to the between-groups analysis of the studies comparing 
yoga to a waitlist control yielded a similar sized effect (Hedges’ g = 0.61). These results are 
consistent with the results of earlier qualitative reviews that reported promising effects of 
yoga on anxiety (45–47).
The moderator analyses suggested that more yoga practices were associated with greater 
benefits and the higher the level of anxiety at the beginning, the more beneficial the practices 
were. In fact, people with clinically elevated anxiety symptoms benefitted the most. Effect 
sizes were not moderated by study year, gender, presence of a medical disorder, and age. 
Although the quality ratings of the studies were relatively low, the risk of study bias was 
unlikely to moderate the effect. These findings provide preliminary support for Hatha yoga 
as a strategy to reduce symptoms of anxiety. However, the effect was relatively small, 
questioning the use of Hatha yoga as a stand-along treatment strategy for anxiety. Therefore, 
combining Hatha yoga with other strategies specifically focusing on the maintenance of the 
anxiety problems (such as the cognitive and behavioral techniques) seems warranted.
A number of limitations should be noted. First, the results are limited by the relatively few 
well-controlled trials examining the effect of yoga. Better controlled studies are needed to 
clearly demonstrate the benefits of yoga for anxiety symptoms. The relatively limited 
number of studies did not allow for meaningful subanalyses to examine the differential 
effects of yoga on specific anxiety disorder diagnoses or even specific symptoms. 
Furthermore, the relatively greater benefit among people with elevated or clinical symptoms 
of anxiety could be the result of the regression to the mean. Waitlist controlled trials provide 
weak evidence for the efficacy of the active treatment. The gold-standard treatment for 
anxiety disorders is cognitive behavior therapy (CBT). Although effective, there is clearly 
room for further improvement (48). Therefore, one possible design for a future trial might be 
the comparison between CBT, Hatha yoga, a combination, and active placebo condition. 
Finally, it is unclear what the mechanism is through which yoga improves anxiety 
symptoms. While Hatha yoga treatment in nearly all of the included studies contained 
postures and breathing, some studies involved additional treatment components (e.g. 
meditation, mindfulness), and thus further research is needed to best understand the active 
ingredients in Hatha yoga for anxiety. Despite these limitations, the results of this meta-
analysis provide preliminary support for Hatha yoga as a treatment for anxiety.
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Figure 1. Flow diagram of study selection process
aOf the 17 studies, 11 included a comparison between a non-active control group and a 
Hatha yoga group.
Hofmann et al. Page 9
J Evid Based Med. Author manuscript; available in PMC 2017 November 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Funnel plot of precision by Hedges’ g for quality of life measures in the pooled meta-
analysis*
*This funnel plot reflects a random effects model. Horizontal and vertical axes plot the 
effect size and standard error of the effect size, respectively.
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Table 2
Mean Baseline Anxiety Severity for Included Studies
Study Anxiety Measure Sample Mean at Baseline (SD) Baseline Anxiety Severity
Baker 1979 (14)
STAI
38.95 (11.54) Normal
Bernardi 2013 (15) 44.31 (10.15)** Elevated
Bunk 1978 (16) 36.64 (7.5) Normal
Cheema2013 (17) 36.1 (10.4) Normal
Ruggiero 2006 (25) 39.93 (8.84) Normal
Sujatha2014 (26) 46.31 (9.05)** Clinical
Vizcaino 2013 (27) 36.8 (11.22) Normal
Ahmadi 2013 (13)
BAI
12.45 (4.54)* Elevated
Dunn 2009 (14) 18.96 (11.83)** Clinical
Cramer 2015 (18)
HADS-A
5.00 (2.08) Normal
Curtis 2011 (19) 10.83 (4.4)** Clinical
Vorkapic 2014 (28) HAM-A 31.45 (1.7) Clinical
Yoo 2007 (29) DASS-A 4.61 (5.25)** Elevated
Holmer 2005 (21) AIMS2-A 16.83 (3.16) NA+
Moadel 2007 (22) DMI-AS 9.70 (8.11) NA+
Pavan 1982 (23) 16PF-A 7.7 (NA) NA+
Ray 2001 (24) IPAT-A 28.77 (8.80) NA+
*Significantly different from population mean (unpaired t-test) at p < .01;
**p < .001;
+population means and clinical cut-offs not available
Anxiety Measures: BAI = Beck Anxiety Inventory (30); STAI = State-Trait Anxiety Inventory (31); HADS-A = Hospital Anxiety and Depression 
Scale-anxiety subscale (32); AIMS2-A = Arthritis Impact Measurement Scales Revised – Anxiety subscale (33); DMI-AS = Distressed Mood 
Index - Anxious/Sadness factor (34); 16-PF = 16 Personality Factor Questionnaire -Anxiety subscale (35); IPAT-A = IPAT Anxiety Scale 
Questionnaire (36); DASS21-A = Depression Anxiety and Stress Scales (21 item version) - Anxiety subscale (37); HAM-A = Hamilton Anxiety 
Rating Scale (38).
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